Symbiox Investment adopts FY26 financials at 47th AGM

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Symbiox Investment & Trading Co Ltd held its 47th AGM on September 28, 2026, via VC/OAVM
  • Members adopted audited financial statements for the financial year ended March 31, 2026
  • Sunita Show was appointed as Executive Director retiring by rotation
  • Voting results to be submitted to stock exchanges within 48 hours of meeting conclusion
powered bylight_fuzz_icon
52132176

*this image is generated using AI for illustrative purposes only.

Symbiox Investment & Trading Co Ltd held its 47th Annual General Meeting (AGM) on September 28, 2026, via Video Conferencing and Other Audio-Visual Means. The meeting commenced at 1:30 pm and concluded by 1:57 pm, with members approving the audited financial statements for the financial year ended March 31, 2026.

The proceedings were conducted in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Samit Ray, Chairperson of the company, presided over the session. The requisite quorum was present, allowing the formal commencement of business items.

Key resolutions passed

During the AGM, shareholders transacted two primary items of ordinary business:

  1. Consideration and adoption of the Audited Financial Statement of the Company for the financial year ended March 31, 2026, along with the reports of the Board of Directors and Auditors thereon.
  2. Appointment of Sunita Show as a Director retiring by rotation.

Practicing Company Secretary Akhil Agarwal served as the Scrutinizer for the electronic voting process conducted through the NSDL platform. Questions raised by members were addressed satisfactorily by Director Sunita Show.

Director profile details

Sunita Show, who was reappointed during the meeting, serves as an Executive Director liable to retire by rotation. Her profile details disclosed in the AGM notice highlight her role in overall administration and decision-making processes.

Detail Information
Name Sunita Show
DIN 09673548
Age 40 years
First Appointment Date September 5, 2023
Current Position Executive Director
Shares Held (as on March 31, 2026) Nil
Other Listed Board Memberships Nil

The Company Secretary stated that voting results would be submitted to the stock exchanges within 48 hours of the meeting's conclusion. The Scrutinizer's Report will be placed on the company's website following the declaration of results.

Historical Stock Returns for Symbiox Investment & Trading

1 Day5 Days1 Month6 Months1 Year5 Years
-1.00%-1.00%-1.00%+20.00%-28.52%0.0%

How will Sunita Show's reappointment as Executive Director influence Symbiox Investment & Trading Co Ltd's strategic direction in the upcoming fiscal year?

What specific investment strategies or portfolio adjustments are anticipated from the company following the adoption of the FY2026 audited financial statements?

Given the absence of other listed board memberships for key directors, how does the company plan to mitigate potential governance risks associated with limited external oversight?

Symbiox Investment & Trading
View Company Insights
View All News
like17
dislike

Symbiox Investment files FY26 annual report with stock exchanges

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Symbiox Investment files FY26 annual report with BSE, CSE, and MSEI
  • Filing submitted on September 4, 2026, per SEBI LODR Regulation 34
  • 47th AGM scheduled for September 28, 2026, via video conference
  • Record date for voting set at September 21, 2026
powered bylight_fuzz_icon
50050342

*this image is generated using AI for illustrative purposes only.

Symbiox Investment & Trading has filed its annual report for the fiscal year ended March 31, 2026, with the Bombay Stock Exchange, Calcutta Stock Exchange, and Metropolitan Stock Exchange of India Limited.

The filing was submitted on September 4, 2026, in compliance with Regulation 34 of the SEBI (LODR) Regulations, 2015. Khushboo Pitti, the company’s Company Secretary and Compliance Officer, signed the intimation.

AGM and Voting Schedule

The company’s 47th Annual General Meeting is scheduled for September 28, 2026. The book closure period runs from September 22 to September 28, 2026, with a record date of September 21, 2026, to determine shareholder voting eligibility.

The AGM will be conducted via Video Conferencing or Other Audio-Visual Means at 1:30 pm from the registered office in Kolkata. Key agenda items include:

  • Adoption of the Audited Financial Statements for FY26.
  • Approval of auditor and Board reports.
  • Reappointment of Mrs. Sunita Show as an Executive Director.

Mrs. Show, appointed on September 5, 2023, oversees administration and operations. She holds no shares as of March 31, 2026.

E-Voting Details

Remote e-voting is facilitated by National Securities Depository Limited (NSDL). Only shareholders on record as of September 21, 2026, are eligible to vote.

Event Date/Time
Record date September 21, 2026
E-voting starts September 25, 2026, 9:00 am
E-voting ends September 27, 2026, 5:00 pm
Book closure period September 22–28, 2026

Participants joining via VC/OAVM must connect within 15 minutes of the start time. The facility accommodates 1,000 members on a first-come, first-served basis, excluding large shareholders holding 2% or more, promoters, and institutional investors. Proxy appointments are not permitted for this virtual meeting.

Historical Stock Returns for Symbiox Investment & Trading

1 Day5 Days1 Month6 Months1 Year5 Years
-1.00%-1.00%-1.00%+20.00%-28.52%0.0%

How might the reappointment of Mrs. Sunita Show as Executive Director influence Symbiox's operational strategy and administrative efficiency in the upcoming fiscal year?

What specific financial performance metrics from the FY26 audited statements are likely to drive shareholder sentiment during the AGM?

Could the restriction of VC/OAVM participation to only 1,000 members impact the quorum or voting outcomes for minority shareholders?

Symbiox Investment & Trading
View Company Insights
View All News
like18
dislike

More News on Symbiox Investment & Trading

1 Year Returns:-28.52%